Taysha Gene Therapies (TSHA) Times Interest Earned (2020 - 2026)

Taysha Gene Therapies has reported Times Interest Earned for 7 years, with the latest figure at -$0.76 in Q1 2026.

• Quarterly Times Interest Earned rose 69.84% year-over-year to -$0.76 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.32 (up 77.76% YoY) and the FY2025 annual result came in at -$1.35, down 68.82% from the prior year.
• Times Interest Earned grew to -$0.76 in Q1 2026 per TSHA's latest filing, from -$2358.3 in the prior quarter.
• Over five years, Times Interest Earned peaked at -$0.73 in Q2 2023 and troughed at -$2358.3 in Q4 2025.
• A 5-year average of -$149.06 and a median of -$2.22 in 2024 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2023 and 2025: Times Interest Earned jumped 98.38% in 2023, then tumbled 61449.52% in 2025.
• Over 5 years, Times Interest Earned stood at -$26.45 in 2022, then jumped by 53.93% to -$12.19 in 2023, then jumped by 68.56% to -$3.83 in 2024, then sank by 61449.52% to -$2358.3 in 2025, then soared by 99.97% to -$0.76 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$0.76, -$2358.3, and -$1.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.